Skip to content
Date and time
Thursday, February 14, 2019 - 14:30
Address
Guildhall
Frankwell Quay
Shrewsbury
Shropshire
SY3 8HQ
United Kingdom

About the Event

The development of the so-called “omics” technologies (genomics, proteomics, metabonomics for example) has promised to revolutionise areas such as personalized medicine by providing new, mechanistic, diagnostic and prognostic biomarkers of disease and response to therapy.  Are they really useful biomarkers that deliver real insight into the biology of disease?  Professor Ian Wilson, Chair in Drug Metabolism and Molecular Toxicology at Imperial College, explains.

Book Now

 

Directions

Location

Address

Guildhall
Frankwell Quay
Shrewsbury
Shropshire
SY3 8HQ
United Kingdom